StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Milestone Income by Quarter

Milestone Income ($M)

QuarterlyAnnual

Novartis Milestone Income: $11M in Q3 2026, up 57.1% from a year earlier.

Latest, Q3 2026
11
Period ended Sep 30, 2026
Change on a year earlier
+57.1%
7 in Q3 2025
History
17 quarters
Since Q3 2022
Sources
13
Documents cited below

Where the Q3 2026 figure comes from

“|| Milestone income | 11 | 7 | 29 | 96”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K Note 3 & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMilestone Income ($M)Year on yearSource
Q3 2026Sep 30, 202611+57.1%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20265-85.7%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202613-75.9%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202521+950.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20257+16.7%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 202535+150.0%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 202554+800.0%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20242-80.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20246-14.3%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 202414-44.0%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 20246+100.0%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 202310-89.8%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20237-12.5%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 202325–Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 20233–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 202298–Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Milestone Income ($M), quarterly Q3 2022–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/collab-milestones

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.